229 related articles for article (PubMed ID: 11391724)
81. Sustained response to anti-CD20 monoclonal antibody in severe acute primary immune thrombocytopenic purpura: report of one adult case.
Luzzatto G; Cella G; Fabris F
Clin Appl Thromb Hemost; 2006 Jan; 12(1):120-1. PubMed ID: 16444448
[No Abstract] [Full Text] [Related]
82. Primary brain lymphoma in a renal transplant patient: unsuccessful intrathecal treatment with anti-B cell monoclonal antibodies (anti-CD21).
Ben Hmida M; Mhiri C; Mnif J; Hachicha J; Kchaou MS; Riffle G; Binet JL; Jacobs C; Jarraya A
Transplant Proc; 1995 Apr; 27(2):1779-80. PubMed ID: 7725501
[No Abstract] [Full Text] [Related]
83. Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children.
Roganovic J
Eur J Pediatr; 2005 May; 164(5):334. PubMed ID: 15711954
[No Abstract] [Full Text] [Related]
84. CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
Lim SH; Hale G; Marcus RE; Waldmann H; Baglin TP
Br J Haematol; 1993 Jul; 84(3):542-4. PubMed ID: 8217808
[TBL] [Abstract][Full Text] [Related]
85. Immunotherapy for non-Hodgkin's lymphoma.
Vose JM
Oncology (Williston Park); 2001 Feb; 15(2):141-7, 151; discussion 152-5. PubMed ID: 11252930
[TBL] [Abstract][Full Text] [Related]
86. Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.
Ducassou S; Gourdonneau A; Fernandes H; Leverger G; Pasquet M; Fouyssac F; Bayart S; Bertrand Y; Michel G; Jeziorski E; Thomas C; Abouchallah W; Viard F; Guitton C; Cheikh N; Pellier I; Carausu L; Droz C; Leblanc T; Aladjidi N;
Br J Haematol; 2020 Jun; 189(5):931-942. PubMed ID: 32130726
[TBL] [Abstract][Full Text] [Related]
87. High-dose dexamethasone therapy for resistant autoimmune thrombocytopenic purpura.
Godeau B; Bierling P; Oksenhendler E; Castaigne S; Deconinck E; Wechsler B
Am J Hematol; 1996 Apr; 51(4):334. PubMed ID: 8602642
[No Abstract] [Full Text] [Related]
88. Severe bleeding symptoms in refractory idiopathic thrombocytopenic purpura: a case successfully treated with melatonin.
Todisco M; Casaccia P; Rossi N
Am J Ther; 2003; 10(2):135-6. PubMed ID: 12629593
[TBL] [Abstract][Full Text] [Related]
89. Lactic acidosis in a patient with B-cell non-Hodgkin's lymphoma.
Scheurleer-Hommes ML; Schaafsma MR; Kluin-Nelemans JC
Leukemia; 1994 Jun; 8(6):1065-6. PubMed ID: 8207979
[TBL] [Abstract][Full Text] [Related]
90. Progress in the non-Hodgkin's lymphomas.
Yuen AR
Ann Oncol; 1999; 10 Suppl 6():19-22. PubMed ID: 10676549
[No Abstract] [Full Text] [Related]
91. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
Abe K; Ishikawa Y; Ishikawa J; Fujiwara M; Kita Y
Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
[TBL] [Abstract][Full Text] [Related]
92. Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura.
Ojeda-Uribe M; Federici L; Wolf M; Coppo P; Veyradier A
Transfusion; 2010 Mar; 50(3):733-5. PubMed ID: 20609201
[No Abstract] [Full Text] [Related]
93. [Immune thrombocytic purpura as the form of presentation of a non-Hodgkin's lymphoma].
Caminal Montero L; Susano RC; Marroquín AG; Taborcias D
Rev Clin Esp; 1994 Nov; 194(11):998-9. PubMed ID: 7846364
[No Abstract] [Full Text] [Related]
94. Anti-idiotype MoAb effective in B-cell non-Hodgkin's lymphoma.
Oncology (Williston Park); 1994 Jun; 8(6):50, 79. PubMed ID: 8074982
[No Abstract] [Full Text] [Related]
95. Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas.
Marchesi F; Pimpinelli F; Giannarelli D; Ronchetti L; Papa E; Falcucci P; Pontone M; Di Domenico EG; di Martino S; Laquintana V; Mandoj C; Conti L; Cordone I; La Malfa A; Viggiani C; Renzi D; Palombi F; Romano A; Pisani F; Gumenyuk S; Di Bella O; Vujovic B; Morrone A; Ciliberto G; Ensoli F; Mengarelli A
Leukemia; 2022 Feb; 36(2):588-590. PubMed ID: 34545184
[No Abstract] [Full Text] [Related]
96. Idiopathic thrombocytopenic purpura and splenic marginal-zone B-cell lymphoma: a casual correlation?
Magagnoli M; Balzarotti M; Castagna L; Rahal D; Siracusano L; Nozza A; Santoro A
Leuk Lymphoma; 2003 Sep; 44(9):1639-40. PubMed ID: 14565674
[No Abstract] [Full Text] [Related]
97. [Therapeutic approach to chronic autoimmune thrombocytopenic purpura].
Muñiz-Díaz E
Med Clin (Barc); 1991 Nov; 97(16):623-8. PubMed ID: 1766285
[No Abstract] [Full Text] [Related]
98. [Idiopathic thrombocytopenic purpura (ITP)].
Nomura S
Ryoikibetsu Shokogun Shirizu; 2000; (31):181-5. PubMed ID: 11269051
[No Abstract] [Full Text] [Related]
99. [Splenectomy in idiopathic thrombocytopenic purpura].
Herrera Hernández MF; López Karpóvitch X; Rivero Sigarroa E; Odor Morales A; de la Garza Villaseñor L; Vargas F
Rev Invest Clin; 1992; 44(2):283. PubMed ID: 1439319
[No Abstract] [Full Text] [Related]
100. [Safety of monoclonal antibody anti-CD 20 in refractory thrombocytopenic idiopathic purpura].
de Roux Serratrice C; Brandi Y; Caillères S; Brunel V; Allègre T; Blanc AP
Rev Med Interne; 2002 Oct; 23(10):869-70. PubMed ID: 12428493
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
